Scientists develop a blood test to predict how long brain cancer patients will survive
Researchers at the University of Pennsylvania found that glioblastoma patients with higher levels of a biomarker in their blood lived on average half as long after diagnosis and discovered new mutations.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Health | Neurology | University of Pennsylvania